Yimei Li, Ph.D.

Dr. Li’s methodology research interests include survival analysis, longitudinal data analysis, Bayesian methods and clinical trial design. Her current research involves statistical designs and analysis for early phase cancer clinical trials and cancer trials with multiple survival endpoints. Her collaborative research focuses on pediatric oncology, including translational and clinical trials, cancer epidemiology, and behavioral and psychosocial intervention studies.

Selected Publications

  • Knafl GJ , Barakat LP, Hanlon AL, Hardie T, Knafl KA, Li Y, Deatrick J.: Adaptive Modeling: An Approach for Incorporating Nonlinearity in Regression Analyses. Research in Nursing and Health 40(3): 273-282, Jun 2017 Notes: doi: 10.1002/nur.21786.

  • Ying GS, Zhang Q, Lan Y, Li Y, Heitjan D : Cure Modeling in Real-Time Prediction: How Much Does It Help? Contemporary Clinical Trials 59: 30-37, May 2017 Notes: doi: 10.1016/j.cct.2017.05.012.

  • Vujkovic M, Aplenc R, Alonzon TA, Gamis AS, Li Y. : Comparing analytic methods for longitudinal GWAS and a case-study evaluating chemotherapy course length in pediatric AML. A report from the Children’s Oncology Group. Frontiers in Genetics 7: 139, Jul 2016 Notes: doi: 10.3389/fgene.2016.00139.

  • Li Y, Hall M, Fisher BT, Huang YV, Seif AE, Bagatell R, Getz K, Alonzo TA, Gerbing RB, Sung L, Adamson PC, Gamis A, Aplenc R : Merging Children's Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children's Oncology Group. PLoS One 10(11): e0143480, Nov 2015 Notes: doi: 10.1371/journal.pone.0143480.

  • Li Y, Zhang Q: A Weibull multi-state model for the dependence of progression-free survival and overall survival. Statistics in Medicine 34(17): 2497-2513, Jul 2015 Notes: DOI: 10.1002/sim.6501 Epub 2015 Apr 10.

  • Li Y, Mick R, Heitjan DF: Suspension of accrual in phase II cancer clinical trials. Clinical Trials 12(2): 128-138, Apr 2015 Notes: DOI: 10.1177/1740774514562029 Epub 2015 Jan 7.

  • Wileyto EP, Li Y, Chen J, Heitjan DF: Assessing the fit of parametric cure models. Biostatistics 14(2): 340-350, Apr 2013 Notes: doi: 10.1093/biostatistics/kxs043. Epub 2012 Nov 28.

  • Li Y, Heitjan DF: A note on the complementary mixture Pareto II distribution. Communications in Statistics - Theory and Methods 42(2): 201-213, 2013 Notes: doi: 10.1080/03610926.2011.581787.

  • Li Y, Mick R, Heitjan DF: A Bayesian approach for unplanned sample size in phase II cancer clinical trials. Clinical Trials 9(3): 293-302, Jun 2012 Notes: doi: 10.1177/1740774512443429. Epub 2012 Apr 20.

  • Li Y, Wileyto EP, Heitjan DF: Statistical analysis of daily smoking status in smoking cessation clinical trials. Addiction 106(11): 2039-2046, Nov 2011 Notes: doi: 10.1111/j.1360-0443.2011.03519.x. Epub 2011 Aug 18.

  • Li Y, Wileyto EP, Heitjan DF: Prediction of individual long-term outcomes in smoking cessation trials using frailty models. Biometrics 67(4): 1321-1329, Dec 2011 Notes: doi: 10.1111/j.1541-0420.2011.01578.x. Epub 2011 Mar 14.

  • Li Y, Wileyto EP, Heitjan DF: Modeling smoking cessation data with alternating states and a cure fraction using frailty models. Statistics in Medicine 29(6): 627-638, Mar 2010 Notes: doi: 10.1002/sim.3825.